Lemon Balm (Melissa officinalis): Calm, Sleep, and the Dose Where It Stops Helping

Reviewed by the NootropicsJet editorial team · Published: [2-09-2024] · Last updated: [23-08-2026]

Based on the controlled human trials indexed in PubMed for Melissa officinalis and mood, anxiety, sleep or cognition, plus the European Medicines Agency’s assessment report on Melissae folium (EMA/HMPC/196746/2012). Citations are to primary sources or to the regulator’s own review of them.

---

Lemon balm (Melissa officinalis) is sold on the nootropics shelf, which implies it sharpens you. The controlled human trials point somewhere else. The better-replicated findings concern acute calmness and, over weeks, self-reported sleep quality. The cognitive results are mixed — and in the same trial most often cited as proof of “cognitive benefit,” the higher doses reduced self-rated alertness and slowed memory task performance.

By the end of this article you should be able to decide whether lemon balm suits what you actually want, and at what dose.

Key takeaways

• In a crossover RCT in 20 healthy young adults, 600 mg improved accuracy of attention — while the higher doses produced reductions in working and secondary memory, and alertness fell significantly at every timepoint measured (Kennedy et al., 2002, Pharmacol Biochem Behav).
• Under a laboratory stressor, 600 mg raised calmness and lowered alertness; 300 mg increased speed of mathematical processing with no loss of accuracy (Kennedy et al., 2004, Psychosom Med).
• More is not better. In a lemon balm/valerian combination trial, only the lowest dose reduced anxiety, and all three doses produced Stroop task decrements.
• The Alzheimer’s trial in this literature is real, small, unreplicated and confined to a diagnosed population. It says nothing about healthy users.
• The plausible calming mechanism — inhibition of GABA transaminase — is in vitro only. It has not been demonstrated in humans.

What lemon balm actually contains

Melissa officinalis is a lemon-scented perennial in the mint family (Lamiaceae), used in European herbal practice for centuries. Chemically it is a polyphenol plant with a volatile oil attached.

The dominant polyphenol is rosmarinic acid, present at up to roughly 6% of the dried leaf; the European Pharmacopoeia sets a minimum of 1% for the dried herbal substance. Alongside it sit caffeic and chlorogenic acids, flavonoid glycosides of luteolin, apigenin, quercetin and kaempferol, triterpenes including ursolic and oleanolic acid, and an essential oil built around the monoterpene aldehydes citral, neral and citronellal.

This composition matters commercially. Polyphenol-rich water or ethanol extracts and volatile essential oils are chemically different products with different evidence bases. A trial of inhaled essential oil tells you very little about a capsule standardized to rosmarinic acid, and vice versa.

Does lemon balm work? What the trials measured

Lemon balm’s human evidence is real but thin — dominated by small acute crossover studies from a single research group at Northumbria University, plus a handful of longer trials in clinical populations.

Lemon balm for anxiety: what changed on the scales

In healthy adults given a single dose, the reliably replicated finding is an increase in self-rated calmness on the Bond–Lader visual analogue scales — not a change in a clinical anxiety diagnosis.

In the 2002 crossover RCT (n = 20; doses 300, 600 and 900 mg of a 30% methanol extract), self-rated calmness was elevated significantly at 1 and 2.5 hours by the lowest dose (p = 0.01 to 0.05, as rendered in the EMA assessment).

Under an induced laboratory stressor, the 600 mg dose ameliorated the negative mood effects of the task, with significantly increased self-ratings of calmness and reduced self-ratings of alertness (Kennedy et al., 2004, Psychosom Med 66(4):607–613, PMID 15272110 — RCT, n = 18).

Evidence tier: Moderate. Human trials suggest an acute effect on self-rated calmness. All of it comes from one research group, in small samples, acutely. Nobody has run a large, long, independent trial in healthy adults.

Lemon balm for sleep

The signal is weaker than the marketing implies. The most-quoted figure — a 42% reduction in insomnia ratings — comes from a 15-day study with no control group and no blinding, in 20 outpatients. The EMA reviewed that study and judged it insufficient on exactly those grounds. Placebo effects on self-reported sleep are large.

The stronger sleep data come from an eight-week randomized placebo-controlled trial in adults with chronic stable angina, where 3 g/day of dried lemon balm improved Pittsburgh Sleep Quality Index scores and DASS-21 depression, anxiety and stress scores against a real placebo (Haybar et al., 2018, Clin Nutr ESPEN).

Evidence tier: Preliminary. Limited evidence indicates improved self-reported sleep quality over weeks, mostly in stressed or unwell populations. No polysomnography.

If your interest is stimulant replacement rather than evening calm, that is a different problem — see our guide to caffeine-free energy supplements for clean focus.

The cognitive results are not the ones being sold

This is where lemon balm’s marketing and its data separate.

In the 2002 trial, the CDR computerised battery produced a sustained improvement in accuracy of attention at 600 mg (p = 0.0001 to 0.049) — the finding everyone cites. It also produced, in the same participants:

• Significant decreases in working memory and secondary memory at 2.5 and 4 hours after the higher doses (p = 0.0005 to 0.05), with the working-memory reduction more pronounced at 1 and 2.5 hours
• Alertness significantly reduced at all timepoints following the highest dose (p = 0.001 to 0.05)

A follow-up study screened lemon balm samples for cholinergic receptor binding and tested the most cholinergically active dried leaf at 600, 1,000 and 1,600 mg in 20 healthy participants (Kennedy et al., 2003, Neuropsychopharmacology 28(10):1871–1881). Notably, the extract used in the earlier study did not exhibit in vitro cholinergic receptor-binding properties at all — which undercuts the “boosts acetylcholine, therefore boosts memory” story before it starts.

The regulator was blunter still: the EMA noted that the Kennedy cognitive studies used a methanol extract not covered by its monograph, and considered them of questionable relevance to traditional use.

Evidence tier on cognitive enhancement: Preliminary at best, and non-uniform in direction. A compound whose most consistent acute effect is reduced alertness is a poor fit for a working session.

If daytime clarity is the goal, the mechanisms in nootropics for brain fog and the cognitive effects of caffeine are better matched to it.

The Alzheimer’s trial, and why it does not transfer

A four-month randomized placebo-controlled trial in Tehran tested a 45% ethanol leaf extract in patients with mild-to-moderate Alzheimer’s disease, reporting better ADAS-cog and CDR-SB outcomes in the extract group, with agitation more frequent on placebo (Akhondzadeh et al., 2003, J Neurol Neurosurg Psychiatry).

Three things must be said about it.

It is a clinical finding in a diagnosed patient population and is not a treatment claim for anyone else. It has not been independently replicated in more than two decades. And it does not transfer to healthy users: a cognitive gain in impaired patients tells you nothing about cognitively intact adults, in whom the same compound reduced alertness.

The adjacent literature also contains a contradiction most coverage skips. A placebo-controlled trial of Melissa essential oil applied topically reported large agitation improvements in severe dementia (Ballard et al., 2002). A later, adequately powered trial found no evidence that Melissa aromatherapy outperformed placebo or donepezil for the same outcome, as reviewed in the EMA assessment. Citing the positive trial without the null one is a choice, not a summary.

How lemon balm might work

GABAergic — the plausible one. A freeze-dried aqueous extract has been reported to inhibit GABA transaminase, the enzyme that clears GABA, in rat brain homogenate. Less breakdown means more available GABA, the brain’s principal inhibitory signal.

So what: this is a coherent explanation for a calming effect and matches the sedative direction of the human trials. It remains Tier 4 — mechanistically plausible, not demonstrated in humans. No trial has measured human GABA turnover after lemon balm.

Cholinergic — the weak one. Extracts displace nicotinic and muscarinic ligands in human cortical tissue, but weakly and inconsistently. Binding affinity varies sharply between strains and preparations, and the preparation used in the 2002 trial showed no cholinergic binding at all.

So what: the “boosts acetylcholine, therefore boosts memory” story is the weakest link in the chain, and the memory results ran the wrong way for it. Preparation-dependence is also one reason results do not transfer between products.

Lemon balm dosage in research

Doses below are what published human studies used. They are not recommendations.

Longer-term dosing in trials: 600 mg/day of a standardized extract for 15 days (uncontrolled), and 3 g/day of dried leaf for 8 weeks (RCT).

Traditional-use posology (EMA) for adults and adolescents over 12: 1.5–4.5 g of comminuted leaf as an infusion 1–3 times daily, 0.19–0.55 g of powdered leaf 2–3 times daily, or 2–4 mL of a 1:1 liquid extract 1–3 times daily.

The practical read: the dose–response is not linear and not monotonic. Higher intake bought more sedation and, past a point, worse performance. Start at the bottom of the studied range, in the evening, and treat sedation as the expected effect rather than a side effect.

Lemon balm vs valerian

They are usually sold together, and the one trial that tested the combination head-on found that the lowest dose was the one that worked. In 24 healthy volunteers given 600, 1,200 or 1,800 mg of a standardized combination product during laboratory-induced stress, the 600 mg dose reduced anxiety — and participants showed decrements in Stroop task performance after all doses.

Valerian has the larger insomnia literature and a heavier sedative profile; lemon balm’s better-replicated finding is acute daytime calmness within an hour, not sleep architecture. Combining them does not straightforwardly add benefit.

If your problem is stress-driven fatigue rather than evening agitation, that is a different mechanism on a different time course — rhodiola for mental fatigue covers it, and lemon balm is a poor substitute.

Safety, side effects and interactions

Lemon balm has a long consumption history and is GRAS-listed by the FDA as a flavoring. No serious adverse events or deaths were identified in the EMA’s review of the literature or the WHO database. In the Alzheimer’s trial, recorded adverse effects were vomiting, nausea, abdominal pain, dizziness, wheezing and agitation, at low frequency and without a significant excess over placebo.

That said:

• Sedatives, hypnotics, anxiolytics and alcohol. Additive drowsiness is the predictable interaction. The EMA advises a warning about driving and operating machinery.
• Thyroid medication. In vitro and animal data suggest aqueous lemon balm extract may interfere with thyroid-stimulating hormone activity. The EMA states the clinical relevance is unknown — this is preclinical, not a demonstrated human effect. It is still a reason to check first.
• Antidepressants. No well-characterized pharmacokinetic interaction is established, but the overlapping target — mood — makes a clinician conversation the right first step.
• Pregnancy and breastfeeding. Not recommended: reproductive and developmental toxicity data are absent, so safety is unestablished rather than disproven.
• Under-18s. EU-registered products are for adults and adolescents over 12; some are restricted to adults. Data in children under 12 are unavailable.

One rule-out line worth taking seriously: persistent anxiety or insomnia is a clinical question before it is a supplement question. Thyroid dysfunction, sleep apnea, medication side effects and depression all present this way, and none of them is addressed by a leaf extract. If symptoms have lasted more than a couple of weeks, or if you take sedatives, anxiolytics, thyroid medication or antidepressants, speak with a clinician before adding anything.

What a quality lemon balm product looks like

Given how much the trial results depended on the specific preparation, the product criteria matter more here than for most ingredients:

• A named, characterized extract — not “lemon balm leaf” with no further detail.
• Stated standardization. Rosmarinic acid content is the usual marker. The Pharmacopoeia floor for dried leaf is 1%; concentrated extracts are typically well above it.
• A per-serving dose you can locate in the table above, disclosed on the label.
• Third-party testing with a batch certificate you can actually retrieve.
• No proprietary blends. If lemon balm is bundled with valerian and four other botanicals at undisclosed amounts, you cannot place yourself on the dose–response curve — which, on this compound, is the whole decision.

Any product meeting all five is a reasonable candidate. One meeting fewer is not, regardless of what the label promises.

The honest bottom line

Lemon balm is a calming agent with a modest, mostly acute human evidence base and a good safety record. If you want something that reliably raises self-rated calmness within an hour, or a plausible evening wind-down aid, it is a defensible low-risk choice at 300–600 mg.

Who this is not for: anyone buying it for daytime cognitive performance. The trial that made people calmer is the same trial that made them slower and less alert, and the effect scaled with dose. It is also not for people with persistent clinical anxiety or insomnia, who need a diagnosis rather than a capsule, and not for people on sedatives, thyroid medication or antidepressants without a clinician’s input.

Lemon balm sits at the calm-and-sleep end of the nootropics and cognitive enhancers landscape — worth understanding as a category, since the compounds that make you calmer and the compounds that make you sharper rarely overlap.

Frequently asked questions

How long does lemon balm take to work? Acute effects were measured within one hour in the controlled trials, with calmness changes detectable at 1 and 2.5 hours post-dose and, at the highest dose, alertness reductions present at every timepoint across the six hours measured. Sleep-related outcomes in longer trials were assessed after two to eight weeks of daily use.

What is a typical lemon balm dosage? Single doses of 300–600 mg of standardized extract were used in the acute mood trials; 600 mg/day was used in a 15-day uncontrolled study and 3 g/day of dried leaf in an eight-week RCT. The EMA’s traditional-use figures for adults are 1.5–4.5 g of leaf as an infusion 1–3 times daily. The 900 mg dose showed worse performance outcomes than lower doses.

Does lemon balm make you sleepy? Reduced self-rated alertness was a statistically significant finding at the highest single dose in a healthy-adult crossover RCT, present at every timepoint measured, and it also appeared at 600 mg under a laboratory stressor. This is the compound’s most consistent effect, not an occasional side effect. The EMA advises caution regarding driving and machinery.

Can you take lemon balm with valerian? They are commonly sold together, but the only trial to test the combination directly found that only the lowest dose (600 mg) reduced anxiety during laboratory-induced stress, while participants showed Stroop task decrements after all doses tested. Adding the two does not reliably add benefit.

Does lemon balm have side effects? Reported effects in trials were infrequent and mild — nausea, vomiting, abdominal pain, dizziness. No serious adverse events or deaths were identified in EMA or WHO literature reviews. Drowsiness is the expected pharmacological effect rather than an adverse one, and it compounds with alcohol and sedatives.

Is lemon balm good for memory? The human data do not support that. In the trial most often cited for cognitive benefit, working and secondary memory performance decreased at the higher doses, while only attention accuracy improved at 600 mg. The one positive memory result comes from a small, unreplicated trial in diagnosed Alzheimer’s patients and does not transfer to healthy adults.

---

This article is for educational purposes and is not medical advice. Lemon balm is a dietary supplement; these statements have not been evaluated by the Food and Drug Administration, and lemon balm is not intended to diagnose, treat, cure or prevent any disease. In the EU, its status rests on the EMA’s traditional-use monograph rather than an authorized health claim. Consult a qualified healthcare professional before starting any supplement, particularly if you are pregnant, breastfeeding, under 18, or taking prescription medication.

---

---

REFERENCES

1. Kennedy DO, Scholey AB, Tildesley NTJ, Perry EK, Wesnes KA. Modulation of mood and cognitive performance following acute administration of Melissa officinalis (lemon balm). Pharmacol Biochem Behav. 2002;72(4):953–964. doi:10.1016/S0091-3057(02)00777-3. PMID 12062586
2. Kennedy DO, Wake G, Savelev S, Tildesley NTJ, Perry EK, Wesnes KA, Scholey AB. Modulation of mood and cognitive performance following acute administration of single doses of Melissa officinalis (Lemon Balm) with human CNS nicotinic and muscarinic receptor-binding properties. Neuropsychopharmacology. 2003;28(10):1871–1881. doi:10.1038/sj.npp.1300230
3. Kennedy DO, Little W, Scholey AB. Attenuation of laboratory-induced stress in humans after acute administration of Melissa officinalis (Lemon Balm). Psychosom Med. 2004;66(4):607–613. PMID 15272110
4. Kennedy DO, Little W, Haskell CF, Scholey AB. Anxiolytic effects of a combination of Melissa officinalis and Valeriana officinalis during laboratory induced stress. Phytother Res. 2006;20(2):96–102
5. Akhondzadeh S, Noroozian M, Mohammadi M, et al. Melissa officinalis extract in the treatment of patients with mild to moderate Alzheimer’s disease. J Neurol Neurosurg Psychiatry. 2003
6. Haybar H, Javid AZ, Haghighizadeh MH, et al. The effects of Melissa officinalis supplementation on depression, anxiety, stress, and sleep disorder in patients with chronic stable angina. Clin Nutr ESPEN. 2018
7. European Medicines Agency, Committee on Herbal Medicinal Products. Assessment report on Melissa officinalis L., folium. EMA/HMPC/196746/2012